Insured persons who have received "IVF" treatment in specific hospitals next year will receive a maximum of 3,000 yuan (RMB, the same below, about S $ 600) for reimbursement.

According to Zhejiang Daily, the residents who participated in the "West Lake Yijian Insurance" in Hangzhou Commercial Supplement Medical Insurance will be able to obtain a maximum of 3,000 yuan in reimbursement in 2023 to implement the insured citizens who assisted fertility in 2023.EssenceAuxiliary reproductive technology is included in the medical insurance reimbursement policy.

In terms of specific reimbursement, during the treatment of provinces and municipal three medical institutions with specific auxiliary fertility qualifications within Hangzhou, the costs of embryonic culture and embryo transplantation are received.The subsidy of a certain limit, the reimbursement limit for embryonic training is 0.15 million yuan/year, and the reimbursement limit for embryonic transplantation costs is 0.15 million yuan/year.

On August 17 this year, 17 departments including the National Health and Health Commission, the National Development and Reform Commission, etc. issued the guidance on further improvement and implementation of active fertility support measures.Pain and auxiliary reproductive technology projects are included in the scope of payment of medical insurance (including maternity insurance) funds according to procedures.

As an emerging market for the auxiliary reproductive, China may have the tens of billions of blue ocean markets.According to data released by the National Health and Health Commission and the China Population Association, the infertility rates of Chinese childbearing age have climbed from 2.5%to 3%20 years ago to 12%to 15%in recent years.50 million people.

In 2022, the penetration rate of the United States auxiliary reproductive services will reach 32.5%. At the same time, the penetration rate of Chinese auxiliary reproductive services will be only 8.7%, which is 23.8%lower than the United States.The scale of the reproductive industry will continue to expand.